Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
Go back to Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.29 +0.27 (2.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.02 | 52 Week High | $2.18 | |||
| Open | $11.11 | 52 Week Low | $0.30 | |||
| Day High | $11.29 | P/E | N/A | |||
| Day Low | $11.08 | EPS | $-3.32 | |||
| Volume | 61,911 | |||||
